Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces the efficiency and performance of the heart.
The symptoms for atrial fibrillation include weakness, heart palpitations, and shortness of breath. The irregular impulses revoke the heart’s natural pacemaker and cannot control the rhythm of the heart. In normal conditions, the heart beats 60–100 times per minute while in case of atrial fibrillation the heart beat changes to about 100–175 beats per minute which is cured by atrial fibrillation ablation.
Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2269
Atrial Fibrillation (AF) Ablation Market: Regional Outlook
Geographically, the global atrial fibrillation ablation market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant regional market for atrial fibrillation ablation owing to increasing risk factors such as increasing age, obesity diabetes resulting in cardiac diseases. Also the market in North America will rise due to the advancement in the technology and products, strict regulations for patient care and safety in the region.
The atrial fibrillation ablation market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing geriatric population opting for atrial fibrillation ablation procedures to avoid blood clots and strokes causing death of the patient. In addition, initiatives by the governments in the region on providing better healthcare facilities to the population contribute to the growth of the atrial fibrillation ablation market. Europe is expected to have second large share in the global atrial fibrillation ablation market throughout the forecast period.
Atrial Fibrillation (AF) ablation Market: Key Players
The global market for atrial fibrillation ablation is highly fragmented. Examples of some of the key players operating in the global atrial fibrillation ablation market are
- Boston Scientific Corporation
- AtriCure, Inc
- LuxCath LLC
- BIOTRONIK UK Ltd
- Biosense Webster, Inc
- MicroPort Scientific Corporation
- Baylis Medical Company, Inc
- Lepu (Beijing) Medical Devices Co., Ltd.
Atrial Fibrillation (AF) Ablation Market: Segmentation
Tentatively, the global atrial fibrillation ablation market can be segmented on the basis of product type, technology and end users.
Based on product type, the global atrial fibrillation ablation market is segmented as:
- Cryoablation Probes and Pens
- Radiofrequency Clamps
- Temperature controlled radiofrequency Ablators
- Radiofrequency ablation catheters
Based on technology, the global atrial fibrillation ablation market is segmented as:
- Radiofrequency energy
Based on end users, the global atrial fibrillation ablation market is segmented as:
- Super specialty clinics